Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
15.105 USD
10.59 B USD
45.04 B USD
848.70 M
About Eli Lilly and Company
Sector
Industry
CEO
David A. Ricks
Website
Headquarters
Indianapolis
Founded
1876
ISIN
US5324571083
FIGI
BBG01QVYRKH0
Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products consist of diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly in May 1876 and is headquartered in Indianapolis, IN.
Related stocks
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
XS238628644
Eli Lilly and Company 1.625% 14-SEP-2043Yield to maturity
5.86%
Maturity date
Sep 14, 2043
LLY4099975
Eli Lilly and Company 4.65% 15-JUN-2044Yield to maturity
5.65%
Maturity date
Jun 15, 2044
LLY5750032
Eli Lilly and Company 5.1% 09-FEB-2064Yield to maturity
5.45%
Maturity date
Feb 9, 2064
LLY6153503
Eli Lilly and Company 5.65% 15-OCT-2065Yield to maturity
5.44%
Maturity date
Oct 15, 2065
US532457BU1
Eli Lilly and Company 4.15% 15-MAR-2059Yield to maturity
5.42%
Maturity date
Mar 15, 2059
LLY5871804
Eli Lilly and Company 5.2% 14-AUG-2064Yield to maturity
5.41%
Maturity date
Aug 14, 2064
LLY6003397
Eli Lilly and Company 5.6% 12-FEB-2065Yield to maturity
5.40%
Maturity date
Feb 12, 2065
LLY5547405
Eli Lilly and Company 4.95% 27-FEB-2063Yield to maturity
5.39%
Maturity date
Feb 27, 2063
US532457BY3
Eli Lilly and Company 2.25% 15-MAY-2050Yield to maturity
5.38%
Maturity date
May 15, 2050
US532457BT4
Eli Lilly and Company 3.95% 15-MAR-2049Yield to maturity
5.35%
Maturity date
Mar 15, 2049
LLY5750031
Eli Lilly and Company 5.0% 09-FEB-2054Yield to maturity
5.34%
Maturity date
Feb 9, 2054
See all LLY bonds
Curated watchlists where LLY is featured.
Frequently Asked Questions
The current price of LLY is 730.230 USD — it hasn't changed in the past 24 hours. Watch Eli Lilly and Company stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BCS exchange Eli Lilly and Company stocks are traded under the ticker LLY.
LLY stock hasn't changed in a week, the month change is a 11.91% rise, over the last year Eli Lilly and Company has showed a −21.06% decrease.
We've gathered analysts' opinions on Eli Lilly and Company future price: according to them, LLY price has a max estimate of 1,190.00 USD and a min estimate of 700.00 USD. Watch LLY chart and read a more detailed Eli Lilly and Company stock forecast: see what analysts think of Eli Lilly and Company and suggest that you do with its stocks.
LLY stock is 2.07% volatile and has beta coefficient of 0.62. Track Eli Lilly and Company stock price on the chart and check out the list of the most volatile stocks — is Eli Lilly and Company there?
Today Eli Lilly and Company has the market capitalization of 714.53 B, it has increased by 2.27% over the last week.
Yes, you can track Eli Lilly and Company financials in yearly and quarterly reports right on TradingView.
Eli Lilly and Company is going to release the next earnings report on Oct 30, 2025. Keep track of upcoming events with our Earnings Calendar.
LLY earnings for the last quarter are 6.31 USD per share, whereas the estimation was 5.60 USD resulting in a 12.70% surprise. The estimated earnings for the next quarter are 6.36 USD per share. See more details about Eli Lilly and Company earnings.
Eli Lilly and Company revenue for the last quarter amounts to 15.56 B USD, despite the estimated figure of 14.70 B USD. In the next quarter, revenue is expected to reach 16.04 B USD.
LLY net income for the last quarter is 5.66 B USD, while the quarter before that showed 2.76 B USD of net income which accounts for 105.14% change. Track more Eli Lilly and Company financial stats to get the full picture.
Yes, LLY dividends are paid quarterly. The last dividend per share was 1.50 USD. As of today, Dividend Yield (TTM)% is 0.77%. Tracking Eli Lilly and Company dividends might help you take more informed decisions.
Eli Lilly and Company dividend yield was 0.67% in 2024, and payout ratio reached 44.39%. The year before the numbers were 0.78% and 77.91% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Sep 24, 2025, the company has 47 K employees. See our rating of the largest employees — is Eli Lilly and Company on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Eli Lilly and Company EBITDA is 24.33 B USD, and current EBITDA margin is 41.75%. See more stats in Eli Lilly and Company financial statements.
Like other stocks, LLY shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Eli Lilly and Company stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Eli Lilly and Company technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Eli Lilly and Company stock shows the sell signal. See more of Eli Lilly and Company technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.